Nexalin Technology (NXL) Net Income towards Common Stockholders (QoQ) (2021 - 2026)
Powered by 
Analysis
Nexalin Technology (NXL) Net Income towards Common Stockholders (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.79% |
| Mar 31, 2026 | 11.77% |
| Dec 31, 2025 | -4.41% |
| Sep 30, 2025 | -43.98% |
| Jun 30, 2025 | 20.45% |
| Mar 31, 2025 | 29.86% |
| Dec 31, 2024 | -15.73% |
| Sep 30, 2024 | -90.60% |
| Jun 30, 2024 | -22.69% |
| Mar 31, 2024 | -34.11% |
| Dec 31, 2023 | 66.02% |
| Sep 30, 2023 | -179.31% |
| Jun 30, 2023 | -9.89% |
| Mar 31, 2023 | -1.56% |
| Dec 31, 2022 | -142.69% |
| Sep 30, 2022 | 31.78% |
| Jun 30, 2022 | -13.19% |
| Mar 31, 2022 | 34.01% |
| Dec 31, 2021 | 67.30% |